WallStSmart
KRRO

Frequency Therapeutics Inc

NASDAQ: KRRO · HEALTHCARE · BIOTECHNOLOGY

$13.49
+6.98% today

Updated 2026-04-30

Market cap
$196.07M
P/E ratio
P/S ratio
30.68x
EPS (TTM)
$-12.48
Dividend yield
52W range
$5 – $56
Volume
0.2M

Frequency Therapeutics Inc (KRRO) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+4.3%
Last 4 quarters
Revenue YoY growth
-43.1%
Most recent quarter
EPS YoY growth
+27.1%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-35.3%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-80.2%
2025-11-12
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-13$-1.65+22.9%$11.50$12.60+9.6%
2025-11-12$-1.92+15.4%$32.80$6.50-80.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-2.14$-1.65+22.9%$1.29M-43.1%
2025-09-30$-2.27$-1.92+15.4%$1.09M
2025-06-30$-2.17$-2.74-26.3%$1.46M
2025-03-31$-2.62$-2.49+5.0%$2.55M
2024-12-31$-2.51$-2.26+10.1%$2.27M
2024-09-30$-2.61$-2.26+13.4%
2024-06-30$-2.39$-2.43-1.6%
2024-03-31$-2.51$-2.44+2.8%
2023-12-31$-2.36$-25.65-986.9%
2023-09-30$-17.73$-15.50+12.6%
2023-06-30$-0.36$-0.30+16.7%
2023-03-31$-0.42$-0.55-31.0%

Frequently asked questions

Has Frequency Therapeutics Inc beaten earnings estimates?
Frequency Therapeutics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +4.3% over the last 4 quarters.
How does KRRO stock react to earnings?
KRRO stock has moved an average of -35.3% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Frequency Therapeutics Inc's revenue growth rate?
Frequency Therapeutics Inc reported year-over-year revenue growth of -43.1% in its most recent quarter, with EPS growing +27.1% year-over-year.